BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 18305352)

  • 1. Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. I. Taxonomy, fermentation, isolation and structural elucidation.
    Fukumoto A; Kim YP; Matsumoto A; Takahashi Y; Shiomi K; Tomoda H; Omura S
    J Antibiot (Tokyo); 2008 Jan; 61(1):1-6. PubMed ID: 18305352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. II. Biological activities.
    Fukumoto A; Kim YP; Hanaki H; Shiomi K; Tomoda H; Omura S
    J Antibiot (Tokyo); 2008 Jan; 61(1):7-10. PubMed ID: 18305353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosynthesis of mercapturic acid derivative of the labdane-type diterpene, cyslabdan that potentiates imipenem activity against methicillin-resistant Staphylococcus aureus: cyslabdan is generated by mycothiol-mediated xenobiotic detoxification.
    Ikeda H; Shin-Ya K; Nagamitsu T; Tomoda H
    J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):325-42. PubMed ID: 26507838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Structural Revision of Cyslabdan.
    Ohtawa M; Hishinuma Y; Takagi E; Yamada T; Ito F; Arima S; Uchida R; Kim YP; Ōmura S; Tomoda H; Nagamitsu T
    Chem Pharm Bull (Tokyo); 2016; 64(9):1370-7. PubMed ID: 27581641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stemphones, novel potentiators of imipenem activity against methicillin-resistant staphylococcus aureus, produced by Aspergillus sp. FKI-2136.
    Koyama N; Nagahiro T; Yamaguchi Y; Masuma R; Tomoda H; Omura S
    J Antibiot (Tokyo); 2005 Nov; 58(11):695-703. PubMed ID: 16466023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xanthoradones, new potentiators of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Penicillium radicum FKI-3765-2 II. Structure elucidation.
    Yamazaki H; Omura S; Tomoda H
    J Antibiot (Tokyo); 2009 Aug; 62(8):435-7. PubMed ID: 19609292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on terpenoids produced by actinomycetes: oxaloterpins A, B, C, D, and E, diterpenes from Streptomyces sp. KO-3988.
    Motohashi K; Ueno R; Sue M; Furihata K; Matsumoto T; Dairi T; Omura S; Seto H
    J Nat Prod; 2007 Nov; 70(11):1712-7. PubMed ID: 17970596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of nosokophic acid, a predicted intermediate of moenomycins, from nosokomycin-producing Streptomyces sp. K04-0144.
    Koyama N; Tokura Y; Takahashi Y; Tomoda H
    Bioorg Med Chem Lett; 2013 Feb; 23(3):860-3. PubMed ID: 23265883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mode of action of microbial anti-MRSA agents].
    Tomoda H
    Yakugaku Zasshi; 2012; 132(1):37-44. PubMed ID: 22214578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NW-G01, a novel cyclic hexadepsipeptide antibiotic, produced by Streptomyces alboflavus 313: I. Taxonomy, fermentation, isolation, physicochemical properties and antibacterial activities.
    Guo Z; Shen L; Ji Z; Zhang J; Huang L; Wu W
    J Antibiot (Tokyo); 2009 Apr; 62(4):201-5. PubMed ID: 19265870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ioniols I and II, tetracyclic diterpenes with antibacterial activity, from Sphaerococcus coronopifolius.
    Smyrniotopoulos V; Vagias C; Rahman MM; Gibbons S; Roussis V
    Chem Biodivers; 2010 Mar; 7(3):666-76. PubMed ID: 20232335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synergistic antibacterial activity of 1-acetyl-beta-carboline and beta-lactams against methicillin-resistant Staphylococcus aureus (MRSA).
    Shin HJ; Lee HS; Lee DS
    J Microbiol Biotechnol; 2010 Mar; 20(3):501-5. PubMed ID: 20372018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naphthacemycins, novel circumventors of β-lactam resistance in MRSA, produced by Streptomyces sp. KB-3346-5. I. The taxonomy of the producing strain, and the fermentation, isolation and antibacterial activities.
    Fukumoto A; Kim YP; Matsumoto A; Takahashi Y; Suzuki M; Onodera H; Tomoda H; Matsui H; Hanaki H; Iwatsuki M; Ōmura S; Shiomi K
    J Antibiot (Tokyo); 2017 May; 70(5):562-567. PubMed ID: 28293038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nosokomycins, new antibiotics discovered in an in vivo-mimic infection model using silkworm larvae. I: Fermentation, isolation and biological properties.
    Uchida R; Iwatsuki M; Kim YP; Ohte S; Omura S; Tomoda H
    J Antibiot (Tokyo); 2010 Apr; 63(4):151-5. PubMed ID: 20186168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and antibacterial activity of brominated diterpenes from the red alga Sphaerococcus coronopifolius.
    Smyrniotopoulos V; Vagias C; Rahman MM; Gibbons S; Roussis V
    Chem Biodivers; 2010 Jan; 7(1):186-95. PubMed ID: 20087985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meroparamycin production by newly isolated Streptomyces sp. strain MAR01: taxonomy, fermentation, purification and structural elucidation.
    El-Naggar MY; El-Assar SA; Abdul-Gawad SM
    J Microbiol; 2006 Aug; 44(4):432-8. PubMed ID: 16953179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial protein from Streptomyces fulvissimus inhibitory to methicillin resistant Staphylococcus aureus.
    Malik H; Sur B; Singhal N; Bihari V
    Indian J Exp Biol; 2008 Apr; 46(4):254-7. PubMed ID: 18512335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and biological activity of laidlomycin, anti-MRSA/VRE antibiotic from Streptomyces sp. CS684.
    Yoo JC; Kim JH; Ha JW; Park NS; Sohng JK; Lee JW; Park SC; Kim MS; Seong CN
    J Microbiol; 2007 Feb; 45(1):6-10. PubMed ID: 17342048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brominated diterpenes with antibacterial activity from the red alga Sphaerococcus coronopifolius.
    Smyrniotopoulos V; Vagias C; Rahman MM; Gibbons S; Roussis V
    J Nat Prod; 2008 Aug; 71(8):1386-92. PubMed ID: 18597527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diperamycin, a new antimicrobial antibiotic produced by Streptomyces griseoaurantiacus MK393-AF2. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities.
    Matsumoto N; Momose I; Umekita M; Kinoshita N; Chino M; Iinuma H; Sawa T; Hamada M; Takeuchi T
    J Antibiot (Tokyo); 1998 Dec; 51(12):1087-92. PubMed ID: 10048567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.